サマリー

当レポートでは、米国におけるレボカバスチンの市場規模および予測を掲載しています。
米国のレボカバスチン市場収益、2016-2021年、2022-2027年、（百万ドル）
アメリカ合衆国のレボカバスチン市場販売数、2016-2021年、2022-2027年、(Kユニット)
米国のレボカバスチン上位5社（2020年）(%)
レボカバスチンの世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに成長すると予想され、2021-2027年の間にXX％のCAGRで成長すると予想されます。
米国のレボカバスチン市場は、2020年にXX百万米ドル、2027年にXX百万米ドルに達し、予測期間中にXX％のCAGRで成長すると予測されています。
QYResearchは、レボカバスチンのメーカー、サプライヤー、流通業者、業界専門家を対象に、売上高、収益、需要、価格変動、製品タイプ、最近の開発と計画、業界動向、ドライバー、課題、障害、潜在的リスクなど、この業界に関する調査を行いました。
総市場をセグメント別に見ると
米国レボカバスチン市場、タイプ別、2016-2021年、2022-2027年（単位：百万ドル）・（Kユニット）
米国レボカバスチン市場セグメント別割合、タイプ別、2020年(%)
滴下
スプレー

米国のレボカバスチン市場、用途別、2016-2021年、2022-2027年 (百万ドル)&(Kユニット)
米国のレボカバスチン市場セグメント別割合、用途別、2020年(%)
病院
ドラッグストア

競合他社の分析
このレポートでは、以下のような主要な市場参加者の分析も行っています。
主要企業 米国市場におけるレボカバスチンの収益、2016-2021年（推定）、（百万ドル）
主要企業の米国市場におけるレボカバスチンの収益シェア、2020年(%)
主要企業の米国市場におけるレボカバスチンの売上高、2016-2021年（推定）、（Kユニット）
米国市場における主要企業のレボカバスチン売上高シェア、2020年(%)
さらに、本レポートでは、市場における競合他社のプロファイルを紹介しています。主なプレイヤーは以下の通りです。
ジョンソン・アンド・ジョンソン
フィジシャンズトータルケア
ノバルティス
Chauvin Pharmaceuticals
Farmaceutici Formenti Spa
ファーマゴンアス
エステブ
富士フイルムファーマ
コーア・イッセイ
興和創薬
ファイザー
沢井製薬
帝華製薬
スズケン
ファーマー
ボシュロム
若本製薬

ページTOPに戻る

目次

1 Introduction to Research & Analysis Reports
1.1 Levocabastine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Levocabastine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Levocabastine Overall Market Size
2.1 United States Levocabastine Market Size: 2021 VS 2027
2.2 United States Levocabastine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Levocabastine Sales: 2016-2027

3 Company Landscape
3.1 Top Levocabastine Players in United States Market
3.2 Top United States Levocabastine Companies Ranked by Revenue
3.3 United States Levocabastine Revenue by Companies
3.4 United States Levocabastine Sales by Companies
3.5 United States Levocabastine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Levocabastine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Levocabastine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Levocabastine Players in United States Market
3.8.1 List of Tier 1 Levocabastine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Levocabastine Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Levocabastine Market Size Markets, 2021 & 2027
4.1.2 Drops
4.1.3 Spray
4.2 By Type - United States Levocabastine Revenue & Forecasts
4.2.1 By Type - United States Levocabastine Revenue, 2016-2021
4.2.2 By Type - United States Levocabastine Revenue, 2022-2027
4.2.3 By Type - United States Levocabastine Revenue Market Share, 2016-2027
4.3 By Type - United States Levocabastine Sales & Forecasts
4.3.1 By Type - United States Levocabastine Sales, 2016-2021
4.3.2 By Type - United States Levocabastine Sales, 2022-2027
4.3.3 By Type - United States Levocabastine Sales Market Share, 2016-2027
4.4 By Type - United States Levocabastine Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Levocabastine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Drug Store
5.2 By Application - United States Levocabastine Revenue & Forecasts
5.2.1 By Application - United States Levocabastine Revenue, 2016-2021
5.2.2 By Application - United States Levocabastine Revenue, 2022-2027
5.2.3 By Application - United States Levocabastine Revenue Market Share, 2016-2027
5.3 By Application - United States Levocabastine Sales & Forecasts
5.3.1 By Application - United States Levocabastine Sales, 2016-2021
5.3.2 By Application - United States Levocabastine Sales, 2022-2027
5.3.3 By Application - United States Levocabastine Sales Market Share, 2016-2027
5.4 By Application - United States Levocabastine Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Corporation Information
6.1.2 Johnson and Johnson Overview
6.1.3 Johnson and Johnson Levocabastine Sales and Revenue in United States Market (2016-2021)
6.1.4 Johnson and Johnson Levocabastine Product Description
6.1.5 Johnson and Johnson Recent Developments
6.2 Physicians Total Care
6.2.1 Physicians Total Care Corporation Information
6.2.2 Physicians Total Care Overview
6.2.3 Physicians Total Care Levocabastine Sales and Revenue in United States Market (2016-2021)
6.2.4 Physicians Total Care Levocabastine Product Description
6.2.5 Physicians Total Care Recent Developments
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Overview
6.3.3 Novartis Levocabastine Sales and Revenue in United States Market (2016-2021)
6.3.4 Novartis Levocabastine Product Description
6.3.5 Novartis Recent Developments
6.4 Chauvin Pharmaceuticals
6.4.1 Chauvin Pharmaceuticals Corporation Information
6.4.2 Chauvin Pharmaceuticals Overview
6.4.3 Chauvin Pharmaceuticals Levocabastine Sales and Revenue in United States Market (2016-2021)
6.4.4 Chauvin Pharmaceuticals Levocabastine Product Description
6.4.5 Chauvin Pharmaceuticals Recent Developments
6.5 Farmaceutici Formenti Spa
6.5.1 Farmaceutici Formenti Spa Corporation Information
6.5.2 Farmaceutici Formenti Spa Overview
6.5.3 Farmaceutici Formenti Spa Levocabastine Sales and Revenue in United States Market (2016-2021)
6.5.4 Farmaceutici Formenti Spa Levocabastine Product Description
6.5.5 Farmaceutici Formenti Spa Recent Developments
6.6 Farmagon As
6.6.1 Farmagon As Corporation Information
6.6.2 Farmagon As Overview
6.6.3 Farmagon As Levocabastine Sales and Revenue in United States Market (2016-2021)
6.6.4 Farmagon As Levocabastine Product Description
6.6.5 Farmagon As Recent Developments
6.7 Esteve
6.7.1 Esteve Corporation Information
6.7.2 Esteve Overview
6.7.3 Esteve Levocabastine Sales and Revenue in United States Market (2016-2021)
6.7.4 Esteve Levocabastine Product Description
6.7.5 Esteve Recent Developments
6.8 Fujifilm Pharma
6.8.1 Fujifilm Pharma Corporation Information
6.8.2 Fujifilm Pharma Overview
6.8.3 Fujifilm Pharma Levocabastine Sales and Revenue in United States Market (2016-2021)
6.8.4 Fujifilm Pharma Levocabastine Product Description
6.8.5 Fujifilm Pharma Recent Developments
6.9 Koa Isei
6.9.1 Koa Isei Corporation Information
6.9.2 Koa Isei Overview
6.9.3 Koa Isei Levocabastine Sales and Revenue in United States Market (2016-2021)
6.9.4 Koa Isei Levocabastine Product Description
6.9.5 Koa Isei Recent Developments
6.10 Kowa Souyaku
6.10.1 Kowa Souyaku Corporation Information
6.10.2 Kowa Souyaku Overview
6.10.3 Kowa Souyaku Levocabastine Sales and Revenue in United States Market (2016-2021)
6.10.4 Kowa Souyaku Levocabastine Product Description
6.10.5 Kowa Souyaku Recent Developments
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Overview
6.11.3 Pfizer Levocabastine Sales and Revenue in United States Market (2016-2021)
6.11.4 Pfizer Levocabastine Product Description
6.11.5 Pfizer Recent Developments
6.12 Sawai Seiyaku
6.12.1 Sawai Seiyaku Corporation Information
6.12.2 Sawai Seiyaku Overview
6.12.3 Sawai Seiyaku Levocabastine Sales and Revenue in United States Market (2016-2021)
6.12.4 Sawai Seiyaku Levocabastine Product Description
6.12.5 Sawai Seiyaku Recent Developments
6.13 Teika Seiyaku
6.13.1 Teika Seiyaku Corporation Information
6.13.2 Teika Seiyaku Overview
6.13.3 Teika Seiyaku Levocabastine Sales and Revenue in United States Market (2016-2021)
6.13.4 Teika Seiyaku Levocabastine Product Description
6.13.5 Teika Seiyaku Recent Developments
6.14 Suzuken
6.14.1 Suzuken Corporation Information
6.14.2 Suzuken Overview
6.14.3 Suzuken Levocabastine Sales and Revenue in United States Market (2016-2021)
6.14.4 Suzuken Levocabastine Product Description
6.14.5 Suzuken Recent Developments
6.15 Famar
6.15.1 Famar Corporation Information
6.15.2 Famar Overview
6.15.3 Famar Levocabastine Sales and Revenue in United States Market (2016-2021)
6.15.4 Famar Levocabastine Product Description
6.15.5 Famar Recent Developments
6.16 Bausch and Lomb
6.16.1 Bausch and Lomb Corporation Information
6.16.2 Bausch and Lomb Overview
6.16.3 Bausch and Lomb Levocabastine Sales and Revenue in United States Market (2016-2021)
6.16.4 Bausch and Lomb Levocabastine Product Description
6.16.5 Bausch and Lomb Recent Developments
6.17 Wakamoto Pharmaceutical
6.17.1 Wakamoto Pharmaceutical Corporation Information
6.17.2 Wakamoto Pharmaceutical Overview
6.17.3 Wakamoto Pharmaceutical Levocabastine Sales and Revenue in United States Market (2016-2021)
6.17.4 Wakamoto Pharmaceutical Levocabastine Product Description
6.17.5 Wakamoto Pharmaceutical Recent Developments

7 United States Levocabastine Production Capacity, Analysis
7.1 United States Levocabastine Production Capacity, 2016-2027
7.2 Levocabastine Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Levocabastine Supply Chain Analysis
9.1 Levocabastine Industry Value Chain
9.2 Levocabastine Upstream Market
9.3 Levocabastine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Levocabastine Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer